Immunology of brain tumors

Ahmadzadeh, 2005, TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells, J Immunol, 174, 5215, 10.4049/jimmunol.174.9.5215 Akasaki, 2004, Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma, J Immunol, 173, 4352, 10.4049/jimmunol.173.7.4352 Aulwurm, 2006, Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo, Int J Cancer, 118, 1728, 10.1002/ijc.21544 Bacon, 2004, Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D, J Immunol, 173, 1078, 10.4049/jimmunol.173.2.1078 Badie, 2001, Role of microglia in glioma biology, Microsc Res Tech, 54, 106, 10.1002/jemt.1125 Bauer, 1999, Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA, Science, 285, 727, 10.1126/science.285.5428.727 Bertone, 1999, Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes, Eur J Immunol, 29, 23, 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO;2-Y Castriconi, 2003, Transforming growth factor beta 1 inhibits expression of nkp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells, Proc Natl Acad Sci U S A, 100, 4120, 10.1073/pnas.0730640100 Chalupny, 2003, ULBP4 is a novel ligand for human NKG2D, Biochem Biophys Res Commun, 305, 129, 10.1016/S0006-291X(03)00714-9 Chen, 2003, Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3, J Exp Med, 198, 1875, 10.1084/jem.20030152 Cosman, 2001, Ulbps, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor, Immunity, 14, 123, 10.1016/S1074-7613(01)00095-4 Das, 2001, MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function, Immunity, 15, 83, 10.1016/S1074-7613(01)00168-6 Doolittle, 2005, New frontiers in translational research in neuro-oncology and the blood–brain barrier: report of the tenth annual Blood–Brain Barrier Disruption Consortium Meeting, Clin Cancer Res, 11, 421, 10.1158/1078-0432.421.11.2 Eisele, 2006, TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells, Brain, 129, 2416, 10.1093/brain/awl205 Facoetti, 2005, Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors, Clin Cancer Res, 11, 8304, 10.1158/1078-0432.CCR-04-2588 Fecci, 2006, Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma, Cancer Res, 66, 3294, 10.1158/0008-5472.CAN-05-3773 Fenstermaker, 2004, Immunotherapeutic strategies for malignant glioma, Cancer Control, 11, 181, 10.1177/107327480401100306 Friese, 2003, MICA/NKG2D-mediated immunogene therapy of experimental gliomas, Cancer Res, 63, 8996 Friese, 2004, RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo, Cancer Res, 64, 7596, 10.1158/0008-5472.CAN-04-1627 Geissmann, 1999, TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells, J Immunol, 162, 4567, 10.4049/jimmunol.162.8.4567 Genestier, 1999, Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc, J Exp Med, 189, 231, 10.1084/jem.189.2.231 Gomez, 2006, Mechanisms of malignant glioma immune resistance and sources of immunosuppression, Gene Ther Mol Biol, 10, 133 Gorelik, 2001, Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells, Nat Med, 7, 1118, 10.1038/nm1001-1118 Govinden, 2003, Genealogy, expression, and cellular function of transforming growth factor-beta, Pharmacol Ther, 98, 257, 10.1016/S0163-7258(03)00035-4 Grauer, 2007, CD4+foxp3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo, Int J Cancer, 121, 95, 10.1002/ijc.22607 Hayakawa, 2002, Cutting edge: tumor rejection mediated by NKG2D receptor–ligand interaction is dependent upon perforin, J Immunol, 169, 5377, 10.4049/jimmunol.169.10.5377 Hickey, 1991, T-lymphocyte entry into the central nervous system, J Neurosci Res, 28, 254, 10.1002/jnr.490280213 Hishii, 1995, Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro, Neurosurgery, 37, 1160, 10.1227/00006123-199512000-00016 Hussain, 2006, The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses, Neuro-oncol, 8, 261, 10.1215/15228517-2006-008 Jachimczak, 1993, The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma, J Neurosurg, 78, 944, 10.3171/jns.1993.78.6.0944 Jensen, 1998, Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review, Surg Neurol, 49, 189, 10.1016/S0090-3019(97)00218-8 Karman, 2004, Dendritic cells in the initiation of immune responses against central nervous system-derived antigens, Immunol Lett, 92, 107, 10.1016/j.imlet.2003.10.017 Kempuraj, 2004, T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors, Int J Immunopathol Pharmacol, 17, 57, 10.1177/039463200401700108 Kumar, 2006, Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients, Oncol Rep, 15, 1513 Lanier, 2003, Natural killer cell receptor signaling, Curr Opin Immunol, 15, 308, 10.1016/S0952-7915(03)00039-6 Lanier, 2005, NK cell recognition, Annu Rev Immunol, 23, 225, 10.1146/annurev.immunol.23.021704.115526 Lauro, 1986, Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells, Acta Neuropathol (Berl), 69, 278, 10.1007/BF00688305 Leitlein, 2001, Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases, J Immunol, 166, 7238, 10.4049/jimmunol.166.12.7238 Ludviksson, 2000, The effect of TGF-beta1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells, Eur J Immunol, 30, 2101, 10.1002/1521-4141(200007)30:7<2101::AID-IMMU2101>3.0.CO;2-P Ohshima, 2003, Differential chemokine, chemokine receptor, cytokine and cytokine receptor expression in pulmonary adenocarcinoma: diffuse down-regulation is associated with immune evasion and brain metastasis, Int J Oncol, 23, 965 Oklu, 2000, The latent transforming growth factor beta binding protein (LTBP) family, Biochem J, 352, 601, 10.1042/0264-6021:3520601 Parney, 2000, Human glioma immunobiology in vitro: implications for immunogene therapy, Neurosurgery, 46, 1169, 10.1097/00006123-200005000-00030 Parney, 2000, Glioma immunology and immunotherapy, Neurosurgery, 46, 778 Parsa, 2007, Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma, Nat Med, 13, 84, 10.1038/nm1517 Platten, 2003, Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas, Ann Neurol, 54, 388, 10.1002/ana.10679 Roth, 2006, Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression, Cancer Res, 66, 3852, 10.1158/0008-5472.CAN-05-3062 Roth, 2007, Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1, Cancer Res, 67, 3540, 10.1158/0008-5472.CAN-06-4783 Russell, 2002, Lymphocyte-mediated cytotoxicity, Annu Rev Immunol, 20, 323, 10.1146/annurev.immunol.20.100201.131730 Saas, 1997, Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?, J Clin Invest, 99, 1173, 10.1172/JCI119273 Saito, 1988, Immunohistochemical analysis of tumor-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors, Surg Neurol, 29, 435, 10.1016/0090-3019(88)90137-1 Schartner, 2005, Impaired capacity for upregulation of MHC class II in tumor-associated microglia, Glia, 51, 279, 10.1002/glia.20201 Schweitzer, 2001, Extraneural metastases of primary brain tumors, J Neurooncol, 53, 107, 10.1023/A:1012245115209 Shi, 2003, Mechanisms of TGF-beta signaling from cell membrane to the nucleus, Cell, 113, 685, 10.1016/S0092-8674(03)00432-X Sikorski, 2005, Immunotherapy for malignant glioma: current approaches and future directions, Neurol Res, 27, 703, 10.1179/016164105X49481 Streit, 2005, Role of microglia in the central nervous system's immune response, Neurol Res, 27, 685, 10.1179/016164105X49463a Uhl, 2004, SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo, Cancer Res, 64, 7954, 10.1158/0008-5472.CAN-04-1013 Watters, 2005, Microglia function in brain tumors, J Neurosci Res, 81, 447, 10.1002/jnr.20485 Whiteside, 2006, Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention, Semin Cancer Biol, 16, 3, 10.1016/j.semcancer.2005.07.008 Wick, 2006, Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma, Curr Pharm Des, 12, 341, 10.2174/138161206775201901 Wiendl, 2002, A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape, J Immunol, 168, 4772, 10.4049/jimmunol.168.9.4772 Wintterle, 2003, Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis, Cancer Res, 63, 7462 Wischhusen, 2002, Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma, Cancer Res, 62, 2592 Wischhusen, 2005, HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo, J Neuropathol Exp Neurol, 64, 523, 10.1093/jnen/64.6.523 Yamaguchi, 1997, Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow, Stem Cells, 15, 144, 10.1002/stem.150144